Lung cancer is a malignant disease that begins in the tissues of the lungs, the two spongy organs in the chest responsible for oxygen exchange and carbon dioxide removal. It remains the leading cause of cancer-related death worldwide. Although strongly associated with tobacco use, lung cancer also occurs in individuals who have never smoked. In fact, an estimated 10% to 20% of lung cancer diagnoses occur in never-smokers or those who have smoked fewer than 100 cigarettes in their lifetime All MRI Wellness blog articles.
At MRI Wellness, we believe that understanding the biology, risk factors, and diagnostic pathways of lung cancer empowers patients to take a proactive approach to their health.
Overview and Epidemiology #
Lung cancer develops when normal lung cells acquire genetic mutations in their DNA. These mutations disrupt normal cellular regulation, leading to uncontrolled growth, resistance to cell death (apoptosis), and the formation of tumors. Over time, cancer cells may invade nearby tissue or metastasize to distant organs such as the brain, bones, liver, or adrenal glands.
Globally, lung cancer accounts for more deaths than breast, colorectal, and prostate cancers combined. While smoking remains the most significant risk factor, environmental exposures, occupational carcinogens, and genetic susceptibility also contribute to disease development.
Types of Lung Cancer #
Lung cancer is broadly classified into two primary histologic categories based on how cancer cells appear under a microscope.
Non-Small Cell Lung Cancer (NSCLC) accounts for approximately 80% to 85% of cases. Subtypes include adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Adenocarcinoma is the most common form in both smokers and never-smokers. NSCLC typically grows more slowly than small cell lung cancer and may be treated with surgery, radiation, chemotherapy, targeted therapy, or immunotherapy depending on stage and molecular characteristics.
Small Cell Lung Cancer (SCLC) represents approximately 10% to 15% of lung cancers. It is strongly associated with heavy smoking and tends to grow rapidly and metastasize early. Although often initially responsive to chemotherapy and radiation, recurrence rates are high.
Molecular profiling has become an essential component of modern lung cancer management, identifying targetable mutations such as EGFR, ALK, ROS1, KRAS, and others. Precision medicine approaches continue to reshape treatment algorithms.
Risk Factors #
Smoking is the dominant risk factor, with risk increasing according to both duration and intensity of exposure. However, lung cancer is increasingly recognized in nonsmokers.
Additional risk factors include:
• Secondhand smoke exposure
• Radon gas exposure, particularly in enclosed residential environments
• Occupational exposure to carcinogens such as asbestos, arsenic, chromium, and nickel
• Prior chest radiation therapy
• Chronic lung diseases such as COPD or pulmonary fibrosis
• Family history of lung cancer
Radon is the second leading cause of lung cancer in the United States. It is a naturally occurring radioactive gas that can accumulate indoors and is undetectable without testing.
Symptoms #
Early-stage lung cancer often produces no symptoms, which contributes to delayed diagnosis. When symptoms occur, they may include:
Persistent cough or change in a chronic cough
Chest pain that worsens with deep breathing or coughing
Shortness of breath
Wheezing
Hoarseness
Coughing up blood (hemoptysis)
Unintentional weight loss
Fatigue
When metastasis occurs, symptoms depend on the organ involved. Brain metastases may cause headaches or neurological changes. Bone metastases may result in localized pain. Advanced disease may also cause swelling of the face or neck due to superior vena cava obstruction.
Because symptoms often emerge at later stages, imaging plays a critical role in early identification.
Pathophysiology #
Cigarette smoke contains numerous carcinogens that directly damage lung epithelial cells. Repeated exposure overwhelms cellular repair mechanisms, leading to accumulated DNA mutations. Over time, these mutations drive malignant transformation.
In nonsmokers, carcinogenesis may be influenced by environmental exposures, air pollution, radon, occupational toxins, chronic inflammation, or inherited genetic susceptibility. Ongoing research continues to explore why lung cancer incidence is rising among never-smokers All MRI Wellness blog articles.
Diagnosis and Staging #
The diagnostic pathway for suspected lung cancer typically includes imaging followed by tissue confirmation.
Low-dose CT screening is recommended for high-risk individuals, particularly long-term smokers aged 50 to 80 with significant smoking history. CT scans are highly sensitive for detecting pulmonary nodules.
Further evaluation may include:
Diagnostic chest CT
PET-CT to assess metabolic activity
Bronchoscopy with biopsy
CT-guided needle biopsy
Mediastinal lymph node sampling
Staging is determined using the TNM system (Tumor size, Node involvement, Metastasis). Accurate staging guides treatment planning and prognosis.
Role of Advanced Imaging #
While CT remains the primary screening tool for lung cancer, advanced imaging technologies can provide broader systemic evaluation. Whole-body MRI offers radiation-free, comprehensive imaging of multiple organ systems. For individuals with elevated risk factors or complex clinical histories, this type of imaging can detect abnormalities beyond the lungs, including potential metastatic spread.
At MRI Wellness, full-body MRI scans evaluate 13 organ systems and can identify incidental findings or masses that warrant further investigation. Although MRI is not currently the standard screening modality for primary lung cancer detection, it plays a valuable role in systemic assessment and surveillance strategies.
Complications #
Untreated lung cancer can lead to significant complications:
Pleural effusion (fluid accumulation around the lungs)
Airway obstruction
Hemorrhage
Metastatic disease
Respiratory failure
Early detection significantly improves survival outcomes. Stage I lung cancer has a substantially higher five-year survival rate compared to advanced-stage disease.
Prevention #
There is no guaranteed method to prevent lung cancer, but risk can be significantly reduced through lifestyle and environmental modifications.
Smoking cessation remains the most effective prevention strategy. Quitting at any age reduces future risk.
Additional preventive measures include:
Avoiding secondhand smoke
Testing homes for radon
Using protective equipment in high-risk occupational settings
Maintaining a nutrient-dense diet rich in fruits and vegetables
Regular physical activity
Screening with low-dose CT is recommended for individuals who meet established high-risk criteria.
